Table 1.
Plasma Specimens |
||||||
---|---|---|---|---|---|---|
Specimen Type and VL, copies/mL | VL ≥1000 Copies/mL | VL <1000 Copies/mL | Total | κ Value, Mean ± SE (95% Confidence Interval) | P | Performance of DBS and DPS Specimens, %a |
| ||||||
DBS | 0.78 ± 0.08 (0.62–0.94) | <.001 | Sensitivity, 77.8; specificity, 98.1; PPV, 82.3; NPV, 97.4 | |||
≥1000 | 14 | 3 | 17 | |||
<1000 | 4 | 152 | 156 | |||
Total | 18 | 155 | 173 | |||
DPS | 0.83 ± 0.07 (0.69–0.98) | <.001 | Sensitivity, 77.8; specificity, 99.4; PPV, 93.3; NPV, 97.5 | |||
≥1000 | 14 | 1 | 15 | |||
<1000 | 4 | 154 | 158 | |||
Total | 18 | 155 | 173 |
Viral failure was defined as plasma viral RNA levels ≥1000 copies/mL.
Abbreviations: DBS, dried blood spot; DPS, dried plasma spot; NPV, negative predictive value, PPV, positive predictive value; SE, standard error; VL, viral load.
PPV and NPV were calculated using a 10.4% prevalence of virological failure